John Didsbury, former chief executive officer of Nuada Pharmaceuticals, has joined DARA BioSciences as executive vice president for drug development.
DARA BioScience is focused on drugs and technology to treat metabolic diseases as well as central nervous disorders and cardiovascular problems.
Didsbury has more than 18 years of experience in pharmaceuticals. He was CEO of Nuada from 2002 to 2005. He also was an executive with GlaxoSmithKline earlier in his career.
DARA BioSciences: www.darabiosciences.com
